|
Class |
Name/Company |
Approval Dates and Comments |
|
Antipsoriatic
|
Cyclosporine solution &
capsules
Neoral®
Novartis
|
Approved by the FDA June 19, 1997 for the treatment of
severe recalcitrant psoriasis. Already approved in Canada
and Europe. The previous formulation is being withdrawn.
|
|
Actinic
keratosis
|
Diclofenac gel 3%
Solarase®
Hyal
|
British regulatory authorities have given conditional
acceptance for the treatment of actinic keratosis. Hyal is
presently awaiting approval for this indication in a number
of other countries.
|
|
Artificial skin
|
Dermagraft®
Smith & Nephew
|
Approved by the HPB in Canada August, 1997 as a
human dermal replacement for the treatment of diabetic
foot ulcers.
|
|
Laser
system
|
Er,Cr:Y laser system
Dermalase system®
Biolase Technology
|
Approved by the FDA July, 1997. This laser system utilizes
an air-water spray to cool the tissues during dermatologic
and general surgical procedures.
|
|
Scars
|
Silicon based device
SKAR CARE
Life Medical Sciences
|
Approved by the FDA August, 1997 as an externally worn
device for the management of hypertrophic & keloid scars.
|